| Q37755705 | A hormonal contraceptive for men: how close are we? |
| Q34184141 | Demonstration of progesterone receptor-mediated gonadotrophin suppression in the human male |
| Q37550531 | Effects of Elevated β-Estradiol Levels on the Functional Morphology of the Testis - New Insights |
| Q35544192 | Endocrine intervention for transsexuals |
| Q44223706 | Investigation of a novel preparation of testosterone decanoate in men: pharmacokinetics and spermatogenic suppression with etonogestrel implants |
| Q37084626 | Low-dose testosterone treatment decreases oxidative damage in TM3 Leydig cells |
| Q34388609 | Male contraception: history and development |
| Q44478596 | Physiological testosterone replacement and arterial endothelial function in men. |
| Q24645334 | Preclinical characterization of a (S)-N-(4-cyano-3-trifluoromethyl-phenyl)-3-(3-fluoro, 4-chlorophenoxy)-2-hydroxy-2-methyl-propanamide: a selective androgen receptor modulator for hormonal male contraception |
| Q35207775 | Regulation of testicular function in men: implications for male hormonal contraceptive development |
| Q24201286 | Steroid hormones for contraception in men |
| Q24245039 | Steroid hormones for contraception in men |
| Q24246673 | Steroid hormones for contraception in men |
| Q36861580 | The role of estradiol in male reproductive function. |
| Q80295513 | [Non-deferential male contraception: review of the literature] |